Home › B-Cell Lymphoma › Texas › San Antonio
B-Cell Lymphoma clinical trials in San Antonio, TX
6 studies for B-Cell Lymphoma are looking for participants at sites in and around San Antonio (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
RecruitingPhase 1
- Methodist Children's Hospital, San Antonio
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
RecruitingPhase 2
- Research Site, San Antonio
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RecruitingPhase 1/2
- Texas Transplant Institute, San Antonio
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
RecruitingPhase 3
- Texas Transplant Institute, San Antonio
DALY II USA/ MB-CART2019.1 for DLBCL
RecruitingPhase 2
- Texas Transplant Institute, San Antonio
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
RecruitingPhase 1/2
- SCRI, San Antonio
B-Cell Lymphoma trials in other cities
- New York City, NY19 studies
- Houston, TX16 studies
- Chicago, IL12 studies
- Nashville, TN11 studies
- Philadelphia, PA11 studies
- Rochester, MN10 studies
- Milwaukee, WI9 studies
- Baldwin Park, CA9 studies
- Boston, MA8 studies
- Cleveland, OH8 studies
- Washington, DC7 studies
- Denver, CO7 studies
Other studies in San Antonio
- Non-Small Cell Lung Cancer59 studies
- Colorectal Cancer46 studies
- Breast Cancer46 studies
- Metastatic Cancer44 studies
- Cancer (all types)41 studies
- Obesity39 studies
- Type 2 Diabetes37 studies
- Overweight33 studies
- Pancreatic Cancer31 studies
- Ovarian Cancer31 studies
- Prostate Cancer28 studies
- Endometrial Cancer27 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.